Management of hypereosinophilic syndrome: A prospective study in the era of molecular genetics

Medicine

Volumn 86, Issue 6, 2007, Pages 344-354

  Dahabreh, Issa J ^a   Giannouli, Stavroula ^a   Zoi, Christine ^b   Zoi, Katerina ^b   Voulgarelis, Michael ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HYDROXYUREA; IMATINIB; IMMUNOGLOBULIN E; INTERLEUKIN 5; PREDNISONE; STEROID;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW BIOPSY; BRAIN INFARCTION; CELL POPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOGENETICS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; EOSINOPHIL COUNT; FEMALE; GENE FUSION; GENE MUTATION; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LOW DRUG DOSE; LUNG INFILTRATE; MALE; MONOTHERAPY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; HYDROXYUREA; HYPEREOSINOPHILIC SYNDROME; MALE; MIDDLE AGED; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; ONCOGENE PROTEINS, FUSION; PATIENT SELECTION; PIPERAZINES; PREDNISONE; PROSPECTIVE STUDIES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TRANSLOCATION, GENETIC;

EID: 40149106450     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e31815d108c     Document Type: Article

References (53)